Original Article Essential Medicine Policy in China: Pros and Cons

Shanlian Hu

2013-01-01

Abstract:Objective: To analyze the achievements, issues and policy recommendations for implementing essential medicine system in China after a 3-year effort. Methods: Policy documents analysis and Literature reviews are conducted.

What problem does this paper attempt to address?

Essential medicine policy in China: pros and cons.

Shanlian Hu

DOI: https://doi.org/10.3111/13696998.2012.751176

2013-01-01

Journal of Medical Economics

Abstract:To analyze the achievements, issues and policy recommendations for implementing essential medicine system in China after a 3-year effort.Policy documents analysis and Literature reviews are conducted.From 2009-2011, a series of national essential medicine (EM) policies has been established which contain EM list, organizing production, quality assurance, pricing, tendering and procurement, distribution, rational use, monitoring and evaluation, etc. About 98.8% government-run primary healthcare institutions and 41.5% village health posts are conducting zero-mark-up policy while buying EMs. The average cost per visit, per admission, and per description in outpatient and inpatient departments has declined. The issues with the national EM list cannot meet the requirements of clinical practice at the local level, all provinces have to increase additional 64-455 EMs in their local supplementary list; the limitation of EML in primary healthcare institutions causes patients to transfer directly to secondary or tertiary hospitals to search appropriate treatment; there is no defined regulation or legislation regarding the responsibility and accountability of government to compensate for the financial loss after implementing a zero mark-up policy in primary healthcare institutions. In the future, some innovative reform should be taken into account, such as revising EML, quality assurance, control margins within the distribution system, differential pricing and internal reference-based pricing, waive taxes and import duties of EMs, and separation between prescribing and dispensing in public hospital reform.Establishing a national essential medicine system is a difficult task to accomplish. The role of the zero-mark-up policy of EMs is to cut off the economic profit chain among different stakeholders. Using pharmaceutical profit to subsidize hospital revenue will be gradually eliminated in China.
An Analysis of China's National Essential Medicines Policy

Xiaodong Guan,Huigang Liang,Yajiong Xue,Luwen Shi

DOI: https://doi.org/10.1057/jphp.2011.34

IF: 3.526

2011-01-01

Journal of Public Health Policy

Abstract:Although China embraced the concept of essential medicines in 1979 and issued its first National Essential Medicines List in 1982, until recently China has lacked a comprehensive national essential drug policy. In its most recent health-care reform (2009–2012), the Chinese government explicitly proposed the establishment of a national essential medicines system, and made it one of five top priorities in the coming years. We review the evolution of China's essential medicines policies, explain the importance of fully implementing the essential medicines policy, and analyze recent policy developments surrounding essential medicines.
Essential medicines system reform in China:Achievements and challenges

HU Shan-lian

2012-01-01

Abstract:The paper has summarized the achievements,issues and policy recommendations for implementing essential medicines system in China since 2009.A series of national policies have been established which include essential medicine list,production,quality supervision,pricing,tendering and procurement,rational use of essential medicines,monitoring and evaluation.About 98.8% public primary health institutions and 41.5% village health posts have been conducted the essential medicines system and zero mark-up on sale.However,the 307 essential medicines could not meet the need of medical service in the grass-root health facilities,it will be impact on the volume and quality of health care services,local government was required to give financial subsidy for the loss caused by zero mark-up.The coverage of essential medicine system needs to be expanded into secondary and tertiary hospitals as well as private health sector.The essential medicines list needs to be dynamically adjusted.The balance between the price cutting and quality assurance of essential medicines should be paid more attention.The scientific method of pricing of essential medicines and designated manufacturer to produce some essential medicines needs to be exploited.
International Experiences on Essential Medicine Policy

WU Ruixue,LIU Bao,DING Jingfang,CHEN Lu,WANG Luan,YE Lu

DOI: https://doi.org/10.3969/j.issn.1001-0408.2007.17.002

2007-01-01

Abstract:OBJECTIVE:To study the international experiences on essential medicine policy and to provide useful reference for the establishing and improving of essential medicine policy in China.METHODS:The practice and experiences on essential medicine policy of countries at different level of national income were analyzed.RESULTS & CONCLUSION:Experiences from Austria,India,South Africa and Zimbabwe etc suggest that a good strategy to improve the availability of essential medici-nes should give priority consideration to the pharmaceutical system and develop essential medicine policy on the basis of a holistic framework including essential formulary as well as rational pricing and reimbursement systems.
Analysis on the difficulties of essential medicine policy

Shan-lian HU

DOI: https://doi.org/10.3969/j.issn.1674-2982.2009.04.001

2009-01-01

Abstract:The understanding and confirming of the essential medicine policy has been deepened worldwide,however,there are several difficulties to promote the essential medicine policy in China.This paper attempts to analyze the problems in this issue in some aspects,such as the selection of essential medicine list,the interrelation between national and local lists of essential medicine,the pricing policy,the production and distribution,information management of essential medicines etc.
Strategies and policy recommendations on improving essential medicines system in China

CHEN Wen,JIANG Hong-li,ZHANG Lu-ying,Chen Ming-sheng,WANG Li-jie,MAO Wen-hui

DOI: https://doi.org/10.3969/j.issn.1674-2982.2012.10.001

2012-01-01

Abstract:Based on sample survey for primary healthcare institutions and outpatient prescriptions as well as special theme surveys and key informant interviews in sampled provinces,this study put forward strategies and policy recommendations to improve the essential medicines system in the following fields including update of essential medicines lists,supply of essential medicines,zero markup between wholesale and retail prices for essential medicines and economic reimbursement of primary healthcare institutions,and extensive application of essential medicines system.
Health in China - Traditional Chinese Medicine: One Country, Two Systems

T Hesketh,WX Zhu

DOI: https://doi.org/10.1136/bmj.315.7100.115

1997-01-01

Abstract:China is the only country in the world where Western medicine and traditional medicine are practised alongside each other at every level of the healthcare system. Traditional Chinese medicine has a unique theoretical and practical approach to the treatment of disease, which has developed over thousands of years. Traditional treatments include herbal remedies, acupuncture, acupressure and massage, and moxibustion. They account for around 40% of all health care delivered in China. The current government policy of expansion of traditional facilities and manpower is being questioned because many hospitals using traditional Chinese medicine are already underutilized and depend on government subsidies for survival. Research priorities include randomised controlled trials of common treatments and analysis of the active agents in herbal remedies. As more studies show the clinical effectiveness of traditional Chinese medicine, an integrated approach to disease using a combination of Western medicine and traditional approaches becomes a possibility for the future.
A Comparative Study of National Essential Medicine Lists at Home and Abroad

Shao Rong,Li Ling,Chen Yongfa,Li Xuan

DOI: https://doi.org/10.3969/j.issn.1672-5433.2013.h1.001

2013-01-01

Abstract:Objective: To make recommendations for the improvement of the national essential medicine list (EML) in China through a comparative study of EMLs at home and abroad. Methods: About 22 representative countries at four levels of economic development were selected for the comparative study on the catalogue selection and the content of essential medicines , and the impact factors related to EML were analyzed. Results and Conclusion: Safety, effectiveness, economy and clinical necessary are the common standards and the principles for making the national EML by these countries and the catalogue classification , number of varieties, therapeutic category, period of adjustment are largely consistent , while the insufficiency of drugs for children is still the common problem. In addition , the constitution of EML is mainly affected by the factors such as economic level , race and spectrum of disease and the medical and health care conditions. Referring to the experiences of foreign countries , China should enhance the application of evidence-based medicine and pharmacoeconomics , seek the mainstream varieties of essential medicines abroad and further improve children medication so as to perfect the selection and dynamic adjustment mechanism for essential medicines.
Zero mark-up policy of essential medicines system in China:Problems and recommendations

CHENG Gang,LIU Xiao-yun,HOU Jian-lin,XU Jin,MENG Qing-yue

DOI: https://doi.org/10.3969/j.issn.1674-2982.2011.10.008

2011-01-01

Abstract:The aim of the national essential medicines system is to ensure the people's accessibility to quality drugs.It is the key to the success of drug policy reform that the responses of the relevant stake-holders are consistent with the designed objectives of the reform measures.The zero mark-up drug policy for primary health facilities brings many problems:it is not consistent with the situation that there exists great imbalance in economic development and financing capacity between areas in China,there is no economic stimulus for primary health facilities to achieve the policy objectives,and it hurts both the accessibility of the people to non-essential drugs and the objective of "strengthening the primary health facilities".To overcome these problems,the following alternative measures are recommended:price mark-up policy should be retained for essential drugs,and non-essential drugs should be permitted to use in primary health facilities without price mark-up.
A Review of Promoting Access to Medicines in China - Problems and Recommendations.

Jing Sun,Cecile Jia Hu,Mark Stuntz,Hans Hogerzeil,Yuanli Liu

DOI: https://doi.org/10.1186/s12913-018-2875-6

2018-01-01

BMC Health Services Research

Abstract:BACKGROUND:Despite recent reforms, distorting funding mechanisms and over-prescribing still maintain severe financial barriers to medicines access in China. Complicated and interrelated problems in the pharmaceutical sector require a common framework to be resolved as fragmented solutions do not work. We present a preliminary assessment of the impact of the national healthcare reforms on access to medicines, and propose policy recommendations for promoting universal access to medicines in China.METHODS:Drawing on multiple sources of information, including a review of published literatures and official national data, field investigations in six provinces and interviews with key opinion leaders, this paper presents a preliminary assessment of the impact of the national healthcare reforms on access to medicines, and proposes policy recommendations for promoting universal access to medicines in China.RESULTS:Public expenditure on medicines has been strictly controlled since the national healthcare reforms of 2009. Yet total pharmaceutical expenditure (TPE) and total health expenditure growth rates continuously outpaced the growth of gross domestic product (GDP). With 2.4% of GDP, TPE now exceeds that of most high income countries. The distorted provider and consumer incentives in the Chinese health system have not fundamentally changed. Price-setting and reimbursement mechanisms do not promote cost-effective use of medicines. Inappropriate price controls and perverse financial incentives are the un-resolved root causes of preference of originator brands for some major diseases and shortages of low-cost and low-consumption medicines. In addition, access to expensive life-saving medicines is yet systematically addressed.CONCLUSIONS:The complicated and interdependent problems interact in a way that leads to significant system problems in China, which create dual challenges that both the developing country and the developed countries are facing. To further promote access to medicines, China should speed up the re-assessment of the quality and efficacy of domestically produced generic medicines; coordinate various reforms of price determination, insurance payments, and procurement policies; address medicine shortages through comprehensive policies and legislation; establish specific mechanisms to achieve sustainable equitable access to expensive essential medicines with health technology assessment as a tool to ensure that policy and priority setting are created in a coherent and evidence-based way.
The Impact of China's National Essential Medicine System on Improving Rational Drug Use in Primary Health Care Facilities: an Empirical Study in Four Provinces.

Yan Song,Ying Bian,Max Petzold,Lingui Li,Aitian Yin

DOI: https://doi.org/10.1186/s12913-014-0507-3

2014-01-01

BMC Health Services Research

Abstract:Background The National Essential Medicine System (NEMS) is a new policy in China launched in 2009 to improve the appropriate use of medications. This study aims to examine the outcomes of the NEMS objectives in terms of the rational use of medicines in primary health care facilities in China. Methods A total of 28,651 prescriptions were collected from 146 township health centers in four provinces of China by means of a field survey conducted in 2010-2011. Indicators of rational drug use were extracted and compared using a pre/post design and then evaluated with regard to the World Health Organization (WHO) Standard Guidelines and data from previous research. Results The average number of drugs per prescription decreased from 3.64 to 3.46 (p <<0.01) between 2009 and 2010. Little effect was found for the NEMS on the average number of antibiotics per prescription, but the percentage of prescriptions including antibiotics decreased from 60.26 to 58.48% (p <<0.01). Prescriptions for injections or adrenal corticosteroids also decreased, to 40.31 and 11.16% of all prescriptions, respectively. All these positive issues were also recorded in 2011. However, each of the above values remained higher than WHO standards. The percentage of drugs prescribed from the Essential Drug List increased after the implementation of the NEMS (p <0.01). Where the available data allowed changes in costs to be assessed, the average expense per prescription increased significantly, from 25.77 to 27.09 yuan (p <0.01). Conclusions The NEMS effectively improved rational medicine use in China. However, polypharmacy and the over-prescription of antibiotics and injections remain common. There is still a large unfinished agenda requiring policy improvements. Treatment guidelines, intensive support supervision, and continuing training for both professionals and consumers are the essential actions that need to be taken.
Consideration and Discussion of the Establishment and Improvement of Essential Medicine Financing Mechanism

Guan Xiaodong,Shi Luwen

DOI: https://doi.org/10.3969/j.issn.1672-5433.2013.h1.017

2013-01-01

Abstract:Objective: To provide policy suggestions and scientific references for improving the national essential medicine policy (NEMP) in China. Methods: The accomplishments made since the establishment of NEMP and existing problems were summarized and the public attributes of essential medicines were analyzed theoretically. Results: Since the establishment of NEMP, the policies related to the system elements have been worked out, expenses on drugs decreased, drug quality and rational drug use have been improved. However, the essential medicine selection was not done in a scientific way, it is hard to carry out drug bid procurement in quantity, the reimbursement of essential medicines was subjected to the existing national basic medical insurance system, and the overall reform of the basic medical and health institutions dragged the construction of NEMP. For the above reasons, the goal of equitable access to essential medicines for all has not been achieved. Conclusion: To achieve the goal of access to essential medicines for all, a budget fund to guarantee the supply of essential medicines should be established and the composition elements should function effectively to match the budget fund, and the supply security system of essential medicines needs to be improved.
Investigation on the Difficulties of Implementation of National Essential Drug System

Shibao Li

2010-01-01

Abstract:OBJECTIVE: To provide reference for medical system reform in China. METHODS: According to Primary Medical Institutions Part of National Essential Drugs List (2009 edition), relevant aspects and reality of medical system reform and in China, policy connotation of Essential Drug System were analyzed to investigate the difficulties of implementation of Essential Drug System. RESULTS CONCLUSION: Several problems should be resolved to implement essential drug system effectively, such as benefit assignment and financial support. The implementation of national essential drug system requires various efforts to achieve the goal of Medical Reform.
A review on implementation effects of National Essential Medicine System

Yu FANG,Qian SHEN,Cai-jun YANG,Jie CHANG,Li-na WU,Shi-min YANG

DOI: https://doi.org/10.3969/j.issn.1674-2982.2015.04.03

2015-01-01

Abstract:Objective:To conduct a systematic review on the implementation effects of National Essential Medi-cine System ( NEMS) since the new health care reform and provide some suggestions to further improve the NEMS. Methods:Databases and relevant international organization reports were searched to collect studies related to the im-plementation of NEMS in China. The database search occurred from January 2009 to December 2014. Results:A to-tal of 1 292 studies were finally included, encompassing 1,277 Chinese papers, 12 English papers, and 3 WHO/HAI reports. A lot of researches have been done on NEMS, but the techniques of NEMS evaluation are not perfect. The sample representativeness is poor, and the longitudinal follow-up studies of the microscopic view is insufficient. . Evi-dence-based evaluation research using big data has just started. Conclusions: The research on NEMS should be strengthened. The NEMS evaluation should not only be based on national conditions, but it should also be in combi-nation with an international, multidimensional evaluation framework in terms of availability, affordability and rational drug use, so as to provide evidences to perfect the NEMS.
Important concerns and actions in the implementation of essential medicine system in Shanghai

Jie-ming QU,Wei-ping LI,Ya-bing ZHANG,Wei ZHANG,Tao-hong LU,Jing-ling HUANG,Jiang-jiang HE

DOI: https://doi.org/10.3760/cma.j.issn.1000-6672.2011.07.027

2011-01-01

Abstract:The relevant policies of national essential medicine system were reviewed, major concerns and actions in the implementation of essential medicine system in Shanghai were introduced, and the suggestions to improve the implementation of essential medicine system of Shanghai were made. These provided the information for policy making and provided a useful experience for facilitating the establishment of essential medicine system and the improvement of its implementation in Shanghai as well as China.
Evidence-based Research on the Selection Method System for China's Essential Medicine List

Zhang Hao,Gu Shuyan,Yang Qian,Gao Lin,Zhen Xuemei,Zeng Yuhang,Dong Hengjin

DOI: https://doi.org/10.3760/cma.j.issn.1000-6672.2017.04.016

2017-01-01

Abstract:Objective To find a selection method system appropriate for China's essential drug list.Methods Collection and analysis of technical paper literature on essential drug list developement,adjustment technical papers,and literature on evidence-based medicine,pharmacoeconomics evaluation,and medical insurance budget analysis from WHO and other countries.On such basis,a method system for selecting China's essential medicine list can be proposed,with its feasibility analyzed and demonstrated.Results The GRADE assessment proposed by WHO was used to evaluate the efficacy and safety of the drug;the pharmacy economics evaluation is added to assess the economic efficiency;these were aided by the pharmacoeconomics evaluation for a comprehensive evaluation of the pharmacoeconomics of the drug in question,supplementing analysis of the medical insurance,and ensuring its affordability of essential medicine so selected.The theory of this system is well developed,and supporting software ready for application.Examples in Zhejiang Province regarding essential medicine for diabetes have proved this method feasible.Data acquisition constitutes a major roadblock for scientific selection due to barriers against medical insurance data sharing.Conclusions Theoretic basis and method tools are fully available for essential medicine selection,and the selection method system as proposed in this study prove feasible to some extent.Decision makers are recommended to scientifically select the essential drugs,and to encourage data sharing,in order to make the list more scientific and pragmatic.
A Survey of Availability, Price and Affordability of Essential Medicines from 2011 to 2016 in Chinese Secondary and Tertiary Hospitals

Xiaodong Guan,Huajie Hu,Chunxia Man,Luwen Shi

DOI: https://doi.org/10.1186/s12939-018-0870-5

2018-01-01

International Journal for Equity in Health

Abstract:BackgroundEssential medicines are those drugs that satisfy the priority health care needs of the population and help with functioning healthcare systems. Although many countries have formulated an essential medicine list, almost half of the global population still lack regular access to essential medicines. Research about the initiation of National Essential Medicines Policy in Chinese secondary and tertiary hospitals is inadequate, and the long-term effect on access after the reform is still unknown. This study's objective was to investigate the access to essential medicines in mainland China's secondary and tertiary hospitals.MethodsData on the access to 30 essential medicines from China's National Essential Medicine List were obtained from China Medicine Economic Information database covering 396 secondary hospitals and 763 tertiary hospitals. We improved the standard methodology developed by the World Health Organization and the Health Action International to measure the availability, median price ratio (MPR) and the incidence of catastrophic drug expenditure (CDE).ResultsFive essential medicines had >50% availability and the nationwide availability kept steady; availability of drugs in eastern regions of China was significantly higher than the central and western regions. The median MPR of 30 drugs nationwide kept steady approximately 5; MPR of drugs in the eastern regions was significantly higher than the central and western regions and the ratio of MPR of innovator brands to generics increased from 3.66 to 6.32 during the study period. The incidence of CDE caused by essential medicines decreased from 2011 to 2014; brand name medicines were more likely to cause CDE than generics and rural patients have a greater tendency to fall into CDE.ConclusionsAfter the implementation of National Essential Medicines Policy, the MPR of essential medicines was well controlled and became more affordable in the context of steady availability. This has highlighted the problems associated with region disparity and inequity between rural and urban areas in the delivery of essential medicines and sustainable mechanisms are needed to deepen the National Essential Medicines Policy in mainland China.
Retrospective Survey of the Efficacy of Mandatory Implementation of the Essential Medicine Policy in the Primary Healthcare Setting in China: Failure to Promote the Rational Use of Antibiotics in Clinics.

Yonghong Xiao,Jin Wang,Ping Shen,Beiwen Zheng,Yingdong Zheng,Lanjuan Li

DOI: https://doi.org/10.1016/j.ijantimicag.2016.06.017

IF: 15.441

2016-01-01

International Journal of Antimicrobial Agents

Abstract:The objective of this study was to understand the impact of implementation of the Essential Medicine Policy (EMP) on the rational use of antibiotics in primary medical institutions in China. A retrospective survey was conducted in 39 primary medical institutions to compare the efficacy of EMP in rational antibiotic use. All institutions completed the survey 1 year before and 1 year after implementation of the EMP. In particular, antibiotic use and its rationality were closely examined. The institutions mainly dealt with common diseases, especially non-infectious chronic diseases. Antibiotic usage was very inappropriate both before and after EMP implementation. Before and after EMP implementation, respectively, the median outpatient cost was US$6.34 and US$5.05, 52.50% (2005/3819) and 53.41% (1865/3492) of the outpatient prescriptions contained antibiotics, and 76.23% (1132/1485) and 78.83% (1106/1403) of inpatients were administered antibiotics. In addition, 98.38% (425/432) and 97.52% (512/525) of surgical inpatients were administered antibiotics, respectively, and 80.76% (638/790) and 75.19% (503/669) of patients with a cold were prescribed antibiotics, respectively. The most commonly used antibiotics were broad-spectrum and injectable agents, including cephalosporins, fluoroquinolones and penicillins. This profile showed little change following implementation of the EMP. In conclusion, inappropriate antibiotic use is a serious problem in primary medical institutions in China. Whilst enforcing the EMP reduced the cost of medical services, it had little effect on promoting the rational use of antibiotics.
Comparison of Domestic and International Essential Medicines System

ZHANG Ruoming,PING Qineng,YU Lili,JIANG Qian

DOI: https://doi.org/10.13748/j.cnki.issn1007-7693.2011.10.026

2011-01-01

Abstract:OBJECTIVE To give some advices on establishing National Essential Medicines System under the circumstance of New Health Reform.METHODS Several typical countries' production,selection,procurement and distribution in essential medicines were compared.RESULTS We can gradually improve National Essential Medicine System and select the most appropriate essential medicines by drawing on international experience.CONCLUSION We have a long way to improve National Essential Medicine System,and need to be paid more attention and support from our country.
Availability and Use of Essential Medicines in China: Manufacturing, Supply, and Prescribing in Shandong and Gansu Provinces.

Wen Chen,Shenglan Tang,Jing Sun,Dennis Ross-Degnan,Anita K Wagner

DOI: https://doi.org/10.1186/1472-6963-10-211

2010-01-01

BMC Health Services Research

Abstract:BACKGROUND:The current health care reform in China launched in 2009 tackles the problem of access to appropriate medicines for its 1.3 billion people by focusing on providing essential medicines to all. To provide evidence for the reform process, we investigated the manufacturing, purchasing, and prescribing of essential medicines in two provinces.METHODS:We conducted surveys in 2007 of all manufacturers (n = 253) and of 59 purposively selected retail and 63 hospital pharmacies in Shandong and Gansu provinces to assess production and supply of products on the 2004 National Essential Medicines List (NEML), as well as factors underlying decision making about production and supply. We also reviewed prescriptions (n = 5456) in health facilities to calculate standard indicators of appropriate medicines use.RESULTS:Overall, manufacturers in Shandong and Gansu produced only 62% and 50%, respectively, of the essential medicines they were licensed to produce. Of a randomly selected 10% of NEML products, retail pharmacies stocked up to 60% of Western products. Median availability in hospital pharmacies ranged from 19% to 69%. Manufacturer and retail pharmacy managers based decisions on medicines production and stocking on economic considerations, while hospital pharmacy managers cited clinical need. Between 64% and 86% of prescriptions contained an essential medicine. However, overprescribing of antibiotics (34%-77% of prescriptions) and injectables (22%-61%) for adult non-infectious outpatient consultations was common.CONCLUSIONS:We found that manufacturers, retail pharmacies, and hospital pharmacies paid limited attention to China's 2004 NEML in their decisions to manufacture, purchase, and stock essential medicines. We also found that prescribing of essential medicines was frequently inappropriate. These results should inform strategies to improve affordable access to essential medicines under the current health care reform.

Original Article Essential Medicine Policy in China: Pros and Cons

Essential medicine policy in China: pros and cons.

An Analysis of China's National Essential Medicines Policy

Essential medicines system reform in China:Achievements and challenges

International Experiences on Essential Medicine Policy

Analysis on the difficulties of essential medicine policy

Strategies and policy recommendations on improving essential medicines system in China

Health in China - Traditional Chinese Medicine: One Country, Two Systems

A Comparative Study of National Essential Medicine Lists at Home and Abroad

Zero mark-up policy of essential medicines system in China:Problems and recommendations

A Review of Promoting Access to Medicines in China - Problems and Recommendations.

The Impact of China's National Essential Medicine System on Improving Rational Drug Use in Primary Health Care Facilities: an Empirical Study in Four Provinces.

Consideration and Discussion of the Establishment and Improvement of Essential Medicine Financing Mechanism

Investigation on the Difficulties of Implementation of National Essential Drug System

A review on implementation effects of National Essential Medicine System

Important concerns and actions in the implementation of essential medicine system in Shanghai

Evidence-based Research on the Selection Method System for China's Essential Medicine List

A Survey of Availability, Price and Affordability of Essential Medicines from 2011 to 2016 in Chinese Secondary and Tertiary Hospitals

Retrospective Survey of the Efficacy of Mandatory Implementation of the Essential Medicine Policy in the Primary Healthcare Setting in China: Failure to Promote the Rational Use of Antibiotics in Clinics.

Comparison of Domestic and International Essential Medicines System

Availability and Use of Essential Medicines in China: Manufacturing, Supply, and Prescribing in Shandong and Gansu Provinces.